IL-15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis.

Toshimasa Shimizu Tomohiro KogaK FurukawaY HoraiK FujikawaA OkadaM OkamotoYushiro EndoS TsujiA TakataniM UmedaShoichi FukuiR SumiyoshiS-Y KawashiriN IwamotoT IgawaK IchinoseM TamaiN SakamotoHideki NakamuraT OriguchiH MukaeM KuwanaA Kawakami

Published in: Journal of internal medicine (2020)

This study identified a combination of biomarkers predicting PM/DM-RPILD progression, and IL-15 is an important cytokine for predicting RPILD development and reflecting ILD severity.

Keyphrases

interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
multiple sclerosis
air pollution
particulate matter
type diabetes
heavy metals
skeletal muscle
metabolic syndrome
systemic lupus erythematosus
disease activity